Skip to main content
Caplight Logo









RxCap

RxCap

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.rxcap.com/

Last Round

Series B

Apr 25, 2024

Total Funding Raised

$19.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RxCap is a healthtech company that provides a platform of connected remote monitoring solutions, including smart devices and software, to improve medication adherence and patient engagement for healthcare providers, payers, and pharmaceutical manufacturers.

Sector

Healthcare & Life Sciences

Verticals

Health IoT, Medical Devices, Patient Engagement, EHR & EMR, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

medication adherenceremote patient monitoringRPMsmart pill bottlesmart pill organizerdigital healthhealth IoTEHR integrationmedication compliancepatient engagementconnected healthmedication managementhealthcare analyticsadherence techAPI platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RxCap Comparables

Compare RxCap with similar companies based on industry and business-model similarity.

RxCap comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AdhereTech
83%
Vaica Medical
82%
InHandPlus
79%

RxCap Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 25, 2024

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 1205% MoM, reaching 2K.

  • May 16, 2026

    Monthly visitors increased 139% MoM, reaching 1.1K.

RxCap Filings

Explore SEC and related filing metadata, where available.

RxCap filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RxCap's valuation, stock price, and market status.

Is RxCap a public or private company?

RxCap is a private company.

What is the current stock price of RxCap?

RxCap is a private company with no public stock price. No recent secondary market data is available.

How much is RxCap worth (valuation)?

Valuation information for RxCap is not publicly available.

Can I buy RxCap stock?

RxCap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RxCap's last funding round?

RxCap's most recent funding round was Series B on April 29, 2024.

Who are the main investors in RxCap?

Investor information for RxCap is not publicly disclosed.

Will RxCap IPO soon?

No public IPO plans have been announced for RxCap.

How can I track RxCap secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RxCap's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range11
Year Founded2019
Last FundingApr 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?